...
首页> 外文期刊>Seminars in Oncology >BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.
【24h】

BRCA1 and BRCA2 variants of uncertain significance. Part two: medical management.

机译:BRCA1和BRCA2变体的意义不确定。第二部分:医疗管理。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In Part One we presented three cases of women with a personal and strong family history of breast cancer, all of whom were tested for BRCA mutations and found to have variants of uncertain significance (VUS), one of which was classified as a polymorphism. While polymorphic variants are typically accepted as being harmless changes that are not deleterious, these findings, along "with the presence of VUS, can nonetheless be unsettling for both clinician and patient when the patient has a personal and/or family history that fits the characteristics for a hereditary cancer syndrome. We asked cancer genetics experts for their guidance on risk assessment and presented their responses in Part One.
机译:在第一部分中,我们介绍了三例具有个人和强烈乳腺癌家族病史的女性病例,所有这些病例均进行了BRCA突变测试,发现具有不确定性显着性(VUS)变体,其中一个被分类为多态性。尽管多态变体通常被认为是无害且无害的变化,但这些发现以及“伴随VUS的存在,当患者具有适合其特征的个人和/或家族病史时,仍可能使临床医生和患者感到不安我们要求癌症遗传学专家提供有关风险评估的指导,并在第一部分中介绍了他们的对策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号